Hijacking tumor metabolism via sonocatalysis to orchestrate cuproptosis-pyroptosis coupling for potent antitumor
Ruixin Luo1, Lile Dong2, Aihong Chen1
1School of Chemistry and Chemical Engineering, Shanghai Frontiers Science Research Center for Druggability of Cardiovascular noncoding RNA, Shanghai Engineering Technology Research Center for PharmaceuticalIntelligent Equipment, Institute for Frontier Medical Technology, ShanghaiUniversity of Engineering Science, Shanghai, 201620, China.
Abstract:
In response to the high metabolic resilience and immunosuppression characteristic of triple-negative breast cancer, this study established a CuGaO2 (CGO) nano sonocatalytic platform to reshape the therapeutic landscape through a metabolic hijacking dual death cascade strategy. The ultrasound activates CGO to generate reactive oxygen species (ROS), and facilitates the release of Cu+ and Ga3+ in tumor. The Ga3+ precisely disrupts iron metabolism and suppresses the expression of Fe-S cluster proteins via the metal mimicry effect, thereby achieving metabolic disarmament at a fundamental level. The decrease of Fe-S proteins, along with Cu+-induced dihydrolipoamide S-acetyltransferase (DLAT) oligomerization, results in dual protein toxicity, causing mitochondrial impairment and triggering efficient cuproptosis. ROS further directly damage mitochondria, leading to a reduction in ATP production. The consequent ion pump failure, coupled with oxidative stress, precisely triggers the caspase-1-mediated pyroptosis pathway. The inflammatory explosion interwoven with cuproptosis and pyroptosis, significantly amplifies cellular damage and promotes the release of immunogenic signals. In vivo results show that the system not only inhibits primary tumor growth, but also makes macrophages become a pro-inflammatory type, and increases CD8+ T cell infiltration, so it inhibits distant metastatic lesions. This cascade strategy offers a novel synergistic approach to overcoming metabolic resistance and metastasis in refractory tumors.
Related Concept Videos
Tumor Immunotherapy
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
